chloroquine has been researched along with artemisinin in 238 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (8.40) | 18.7374 |
1990's | 22 (9.24) | 18.2507 |
2000's | 58 (24.37) | 29.6817 |
2010's | 116 (48.74) | 24.3611 |
2020's | 22 (9.24) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M | 1 |
Avery, VM; Duffy, S; Khalaf, AI; Scott, FJ; Suckling, CJ | 1 |
Brun, R; Faist, J; Kaiser, M; Saf, R; Seebacher, W; Weis, R | 1 |
Khan, SI; Ponnan, P; Rawat, DS; Reddy, PL; Tripathi, M | 1 |
Dong, G; Liu, N; Sheng, C; Wang, Y; Wu, S | 1 |
Avery, VM; Baell, JB; Bullen, HE; Cowman, AF; Crabb, BS; Curtis, JM; Di Rago, AE; Duffy, S; Gilson, PR; Hutton, CA; Jarman, KE; Jousset Subroux, H; Lowes, KN; Nguyen, W; Prinz, B; Sleebs, BE; Tan, C | 1 |
Bahuguna, A; Khan, SI; Kumar, D; Maurya, SS; Rawat, DS | 1 |
Faist, J; Hochegger, P; Kaiser, M; Mäser, P; Saf, R; Seebacher, W; Weis, R | 2 |
Mahajan, S; Vijayaraghavan, S | 1 |
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK | 1 |
Gut, J; Kumar, S; Kumar, V; Raj, R; Rosenthal, PJ; Saini, A | 1 |
Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M | 1 |
Brun, R; Kaiser, M; Mazzieri, MR; Nieto, MJ; Pagliero, RJ | 1 |
Feng, LS; Gao, C; Hu, YQ; Wu, X; Xu, L; Xu, Z; Zhang, S; Zhao, F | 1 |
Gut, J; Kumar, V; Rani, A; Rosenthal, PJ; Singh, A | 1 |
Akisue, G; Endo, Y; Etoh, T; Fukuyama, Y; Harada, K; Hirano, T; Ishibashi, M; Ishiyama, A; Iwatsuki, M; Kagechika, H; Kasahara, T; Kubo, M; O Mura, S; Ohsaki, A; Otoguro, K | 1 |
Arrizabalaga, G; Fargnoli, L; Khan, SI; Labadie, GR; Panozzo-Zénere, EA; Porta, EOJ; Tekwani, BL | 1 |
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK | 1 |
Çapcı Karagöz, A; Efferth, T; Friedrich, O; Gruber, L; Hahn, F; Hampel, F; Kappes, B; Klein, V; Leidenberger, M; Marschall, M; Reiter, C; Seo, EJ; Tsogoeva, SB | 1 |
Equbal, D; Mohanakrishnan, D; Sahal, D; Sharma, N; Sharma, UK; Sinha, AK | 1 |
Dunn, BM; Durvasula, R; Grishina, M; Gupta, N; Kempaiah, P; Kumar Singh, A; Kumar, P; Kumar, Y; Miller, W; Potemkin, V; Rajendran, V; Rathi, B; Singh, A; Singh, BK; Singh, S | 1 |
Alvarez, S; Arnett, SD; Ball, H; Boshoff, HI; Brothers, RC; Couch, RD; Dowd, CS; Edwards, RL; Girma, M; Haymond, A; Johnson, C; Manikkam, M; McKay, KT; Meyers, MJ; Odom John, AR; Osbourn, DM; Wang, X | 1 |
Bahuguna, A; Khan, SI; Kholiya, R; Kumar, D; Maurya, SS; Rawat, DS | 1 |
Danton, O; Hamburger, M; Kaiser, M; Moridi Farimani, M; Nejad Ebrahimi, S; Neuburger, M; Potterat, O; Ramseyer, J; Salehi, P; Tabefam, M | 1 |
Battista, MR; Brun, R; Calvet, CM; Cirilli, R; Costi, R; De Leo, A; De Vita, D; Di Marco, A; Di Santo, R; Faggi, C; Jennings, GK; Kaiser, M; Madia, VN; Mäser, P; Messore, A; Pepe, G; Pescatori, L; Podust, LM; Saccoliti, F; Scipione, L; Summa, V; Tudino, V | 1 |
Aguiar, ACC; de Souza, JO; Fagundez, C; Gamo, FJ; Guido, RVC; Ottilie, S; Peña, S; Sanz, LM; Scarone, L; Sellanes, D; Serra, GL; Stewart, L; Winzeler, EA; Yardley, V | 1 |
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Wang, WL | 1 |
Adah, D; Chen, X; Dai, L; Goldberg, DE; Guan, J; Leng, F; Li, X; Liu, J; Liu, X; Liu, Z; Lu, Y; Ma, H; McNitt, SA; Meyers, MJ; Nasamu, AS; Polino, AJ; Qin, L; Tortorella, MD; Tu, Z; Xu, J; Zhao, S | 1 |
Charman, SA; Grau, GER; Gut, J; Hunt, NH; Juillard, A; Legac, J; Payne, RJ; Rosenthal, PJ; Stoye, A; Tang, AH; White, KL | 1 |
Cheong, SL; Ng, CH; Tibon, NS | 1 |
Adhikari, N; Gaikwad, VR; Govindarajalu, G; Karale, UB; Krishna, EV; Krishna, VS; Misra, S; Rode, HB; Sijwali, PS; Sriram, D | 1 |
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Dolensky, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Petritsch, M; Saf, R; Schühly, W; Seebacher, W; Weis, R | 1 |
Abramo, C; David da Silva, A; de Almeida Pimentel, G; de Pilla Varotti, F; Glanzmann, N; Gualberto Pereira, HM; Karine da Costa Nunes, I; Marinho, JA; Martins Guimarães, DS; Navarro, M | 1 |
Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
Akao, Y; Avery, VM; Charman, SA; Chen, G; Chen, X; Chiu, FCK; Cho, N; Crespo, B; Dechering, KJ; Duffy, S; Kamaura, M; Katneni, K; Laleu, B; Lucantoni, L; Ochida, A; Sanz, LM; Shackleford, DM; Sturm, A; Wang, B; White, KL; Wittlin, S | 1 |
Almolhim, H; Bremers, EK; Butler, JH; Butschek, GJ; Carlier, PR; Cassera, MB; Ding, S; Merino, EF; Rizopoulos, Z; Slebodnick, C; Totrov, M | 1 |
Hokari, R; Inahashi, Y; Koomsiri, W; Leetanasaksakul, K; Matsuo, H; Nakashima, T; Shiomi, K; Suga, T; Takahashi, YK; Thamchaipenet, A; Wattana-Amorn, P | 1 |
Trigg, PI | 1 |
Bourdeau, EF; Childs, GE; Milhous, WK; Pang, L; Wimonwattratee, T | 1 |
Gu, HM; Inselburg, J | 1 |
Castranova, V; Van Dyke, K; Ye, ZG | 1 |
Walter, RD | 1 |
Kirk, RG; Lee, P; Van Dyke, K; Ye, Z | 1 |
Druilhe, P; Gentilini, M; Stahel, E | 1 |
Chen, L; Gu, HM; Li, GD; Li, J; Qian, YL; Waki, S; Zhu, MY | 1 |
Carroll, FI; Kepler, JA; Lee, YW; Morey, MC; Philip, A | 1 |
Du, YL; Jiang, Q; Li, CS | 1 |
Van Dyke, K; Wimmer, M; Ye, ZG | 1 |
Choudhury, DS; Devi, CU; Ghosh, SK; Sharma, VP; Sinha, S | 1 |
Chawira, AN; Peters, W; Warhurst, DC | 1 |
Chawira, AN; Warhurst, DC | 1 |
Peters, W | 1 |
Beale, GH; Thaithong, S | 1 |
Li, GD | 1 |
Fu, XQ; Gao, MX; Li, GQ; Li, ZL; Liu, HP; Ye, ZG | 1 |
Chiodini, PL; Ellis, CJ | 1 |
Gu, HM; Lu, BF; Qu, ZX | 1 |
Howells, RE | 1 |
Cai, XZ | 1 |
Baric, RS; Bright, P; Handy, J; Peel, SA; Yount, B | 1 |
Basco, LK; Le Bras, J | 2 |
Avery, MA; Chandra-ngam, G; Kamchonwongpaisan, S; Yuthavong, Y | 1 |
Holloway, P; Krishna, S; Pasvol, G; ter Kuile, F; White, NJ | 1 |
Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
White, NJ | 1 |
Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
Bishop, LP; Hawley, SR; Maggs, JL; O'Neill, PM; Park, BK; Storr, RC; Ward, SA | 1 |
Meshnick, SR | 1 |
Heppner, DG; Kawamoto, F; Nguyen, TD; Sookto, P; Trieu, NT; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Van Dyke, K; Ye, Z | 1 |
Alin, MH | 1 |
Cumming, JN; Park, SB; Posner, GH; Shapiro, TA; Wang, D | 1 |
Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
Le Bras, J | 1 |
White, N | 1 |
Akompong, T; Ghori, N; Haldar, K; VanWye, J | 1 |
Benoit-Vical, F; Meunier, B; Robert, A | 2 |
Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 1 |
Jain, GK; Pandey, VC; Puri, SK; Singh, S; Srivastava, P | 1 |
Caruana, SR; Cowman, AF; Kirk, K; Reed, MB; Saliba, KJ | 1 |
Bloland, PB; Ettling, M; Meek, S | 1 |
Ikemoto, N; Ishizuka, Y; Kim, HS; Ko, N; Kobayashi, M; Murakami, N; Shibata, Y; Sugimoto, M; Wataya, Y | 1 |
Etchegorry, MG; Galinski, M; Matthys, F; Nosten, F; White, NJ | 1 |
Angerhofer, CK; Cordell, GA; Han, J; Kim, SU; Lee, JG; Min, SS; Park, SH | 1 |
Faiz, MA; Kawamoto, F; Laoboonchai, A; Lin, K; Noedl, H; Pang, LW; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Kollaritsch, H; Krudsood, S; Looareesuwan, S; Noedl, H; Viriyavejakul, P; Wernsdorfer, WH; Wiedermann, G; Wilairatana, P | 1 |
Chauhan, VS; Kannan, R; Sahal, D | 1 |
Björkman, A; Gupta, S; Mariga, ST; Thapar, MM; Wernsdorfer, WH | 1 |
Ferreras, A; Herrera, F; Sánchez, E; Triana, L | 1 |
Domínguez, JN | 1 |
de Vries, PJ; Heisterkamp, SH; Kager, PA; Le, HQ; Nguyen, NV; Nguyen, TV; Phan, GT; Tran, BQ | 1 |
Bray, PG; Hastings, IM; Ward, SA | 1 |
Fidock, DA; Sidhu, AB; Verdier-Pinard, D | 1 |
Benoit-Vical, F; Camus, D; Capron, M; Delhaes, L; Meunier, B | 1 |
Attaran, A; Barnes, KI; Curtis, C; d'Alessandro, U; Fanello, CI; Galinski, MR; Kokwaro, G; Looareesuwan, S; Makanga, M; Mutabingwa, TK; Talisuna, A; Trape, JF; Watkins, WM | 1 |
Barman, K; Dev, V; Phookan, S | 1 |
Singhal, T | 1 |
Carucci, DJ; Cooper, RA | 1 |
Brown, ML; Geyer, JA; Terrell, JC; Trotta, RF | 1 |
Egan, J; Hoppe, HC; Meredith, SA; van Schalkwyk, DA; Weber, BW; Wiehart, UI | 1 |
Beg, MA; Khan, MA; Razi, ST; Smego, RA | 1 |
Majori, G | 1 |
Garner, P; Omari, A | 1 |
Basilico, N; Mondani, M; Monti, D; Olliaro, P; Parapini, S; Taramelli, D | 1 |
Alexander, N; Alloueche, A; Drakeley, CJ; Hallett, RL; Jawara, M; Ord, R; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
Adams, B; Elandalloussi, LM; Smith, PJ | 1 |
Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, SL; Reingold, A; Rosenthal, PJ; Slater, M; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
Eriksen, J; Gustafsson, LL; Minzi, OM; Nsimba, SE; Petzold, M; Sanga, AJ; Tomson, G; Warsame, MY | 1 |
Akoachere, M; Becker, K; Buchholz, K; Burhenne, J; Fischer, E; Haefeli, WE; Schirmer, RH | 1 |
Bourée, P | 1 |
Krishna, S; Woodrow, CJ | 1 |
de Radiguès, X; Diallo, KI; Diallo, M; Djimdé, A; Doumbo, O; Guthmann, JP; Maiga, H; Ngwakum, PA; Sacko, M | 1 |
Hi, YC; Huang, F; Tang, LH; Wang, QM | 1 |
Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
Fidock, DA; Valderramos, SG | 1 |
Kollaritsch, H; Kyavar, L; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH | 1 |
Congpuong, K; Na-Bangchang, K | 1 |
Benoit-Vical, F; Berry, A; Lelièvre, J | 1 |
Noe, D; Sharma, A; Toler, SM | 1 |
Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
Garcia, CR; Gazarini, ML; Markus, RP; Sigolo, CA; Thomas, AP | 1 |
Afonso, A; Carter, R; Cheesman, S; Cravo, P; Creasey, A; Culleton, R; do Rosario, V; Fidock, DA; Hunt, P; Logan, J; McNae, I; Sidhu, AB; Valderramos, SG | 1 |
D'Altilia, JP; Kindermans, JM; Olliaro, P; Vandenbergh, D; Vreeke, E | 1 |
Benoit-Vical, F; Lelièvre, J; Loup, C; Meunier, B | 1 |
Congpuong, K; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Woitsch, B | 1 |
Chanda, P; Hamer, DH; Olumese, P; Simon, JL; Sipilanyambe, N; Snow, RW | 1 |
Dama, S; Djimdé, A; Doumbo, O; Fofana, B; Hubert, V; Kaddouri, H; Kodio, A; Koné, A; Le Bras, J; Maiga, H; Sangaré, CP; Sidibe, B; Tekete, M; Yattara, O | 1 |
Blumberg, L; Frean, J | 1 |
Ekland, EH; Fidock, DA | 1 |
Bhasin, VK; Bhattacharya, A; Mishra, LC | 1 |
Diarra, M; Guissou, IP; Ouédraogo, LT; Somé, IT | 1 |
Priebe, W; Saliba, KJ; van Schalkwyk, DA | 1 |
Andrianjafy, T; Juliano, JJ; Raharimalala, LA; Randriamanantena, A; Randrianarivelojosia, M; Raveloson, A; Robert, V | 1 |
Engl, M; Gluderer, D; Ogwang, M; Ploner, F; Ploner, M; Prugger, C; Wernsdorfer, G; Wernsdorfer, WH | 1 |
Co, EM; Dennull, RA; Johnson, JD; Reinbold, DD; Waters, NC | 1 |
Fu, Y; Kenny, S; Klonis, N; Tilley, L | 1 |
Clardy, J; Daily, JP; Demas, A; Lakshmanan, V; LeRoux, M; Mboup, S; Ndiaye, D; Ndir, O; Patel, V; Wirth, DF | 1 |
Oguonu, T; Okafor, HU; Shu, EN | 1 |
Chevalley, S; Coste, A; Lopez, A; Pipy, B; Valentin, A | 1 |
Angus, BJ; Anstey, NM; Douglas, NM; Nosten, F; Price, RN | 1 |
Van Noorden, R | 1 |
Blair, S; Deharo, E; Pabón, A | 1 |
Adelsberger, JW; Baseler, MW; Imamichi, T; Oguariri, RM | 1 |
Bei, ZC; Cao, WC; Wang, H; Wang, JY | 1 |
Bharti, PK; Chand, G; Dash, AP; Mehra, RK; Sharma, RK; Shukla, MK; Shukla, MM; Singh, MP; Singh, N | 1 |
Adhikari, M; Alifrangis, M; Bygbjerg, IC; Kapel, CM; Ranjitkar, S; Schousboe, ML; Thomsen, TT | 1 |
Atheaya, H; Khan, SI; Kumar, N; Mamgain, R; Rawat, DS | 1 |
Bera, DK; Biswas, A; Das, M; Das, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Roy, D; Saha, P; Sengupta, S | 1 |
Congpuong, K; Sirichaisinthop, J; Treiber, M; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U | 1 |
Ensom, MH; Wilby, KJ | 1 |
Kittikool, D; Sibmooh, N; Srihirun, S; Tangnitipong, S; Thaptimthong, T; Udomsangpetch, R; Unchern, S | 1 |
Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
Benedict, C; Crandall, I; Macmullin, G; Pillai, DR; Shahinas, D | 1 |
Garner, P; Gelband, H; Graves, PM | 3 |
Noedl, H | 1 |
Alecrim, Md; Chaves, FC; Costa, MR; Hidalgo, Ade F; Magalhães, PM; Pohlit, AM; Silva, LF; Vieira, PP | 1 |
Mita, T; Tanabe, K | 1 |
Beeson, JG; Goodman, CD; Langer, C; McFadden, GI; Wilson, DW | 1 |
Das Sutar, SK; Dhangadamajhi, G; Kar, SK; Ranjit, M | 1 |
Chugh, M; Kumar, S; Malhotra, P; Reddy, VS; Siddiqui, WA; Stuart, KD; Sundararaman, V | 1 |
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
Fitri, LE; Saragih, A; Zein, U | 1 |
Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
Ayong, L; Freitas-Junior, LH; Hansen, MA; Kang, M; Kim, H; Lee, S; Moon, S | 1 |
Fabre, PL; Ibrahim, H; Najahi, E; Nepveu, F; Perio, P; Reybier, K; Souard, F; Yen, NT | 1 |
Baruah, I; Dhiman, S; Goswami, D; Rabha, B; Sharma, DK; Singh, L; Veer, V | 1 |
Appel, J; Bouraoui, A; Croft, S; Dellai, A; Nefzi, A | 1 |
Amewu, RK; Guedes, RC; Gut, J; Lopes, F; Miranda, D; Moreira, R; Newton, AS; O'Neill, PM; Oliveira, R; Rosenthal, PJ; Srivastava, A; Ward, SA | 1 |
Jegajeevanram, K; Karunamoorthi, K; Sabesan, S; Vijayalakshmi, J | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Flegg, JA; Gharbi, M; Guerin, PJ; Hopkins Sibley, C; Metcalf, CJE; Shewchuk, T; Venkatesan, M | 1 |
Bakshi, RP; Nenortas, E; Shapiro, TA; Sullivan, DJ; Tripathi, AK | 1 |
Anvikar, AR; Arora, U; Kumar, N; Mishra, N; Savargaonkar, D; Shah, NK; Shahi, B; Sonal, GS; Valecha, N | 1 |
Kumar, R; Mohanakrishnan, D; Sahal, D; Sharma, N; Sharma, UK; Sinha, AK | 1 |
Bala, N; Betuela, I; Davis, TM; Hetzel, MW; Lavu, EK; Page-Sharp, M; Pulford, J | 1 |
André-Barrès, C; Mallet-Ladeira, S; Maynadier, M; Ruiz, J; Vial, H | 1 |
Amaratunga, C; Anderson, JM; Chuor, CM; Fairhurst, RM; Mao, S; Sreng, S; Suon, S; Tullo, GS | 1 |
Ahmed, MA; Bhattacharyya, DR; Bora, K; Goswami, BK; Mahanta, J; Mohapatra, PK; Prakash, A; Sarma, B; Sarma, DK | 1 |
Barker, GC; Lapkin, AA; Romero-Canelón, I; Suberu, JO; Sullivan, N | 1 |
Dahlstrom, S; Ferreira, PE; Franzén, O; Gil, JP; Lum, JK; Nosten, F; Osório, NS; Veiga, MI | 1 |
Bhattacharya, S; Chakrabarti, G; Choudhury, D; Datta, S; Ganguli, A | 1 |
Dondorp, A; von Seidlein, L | 1 |
Laufer, MK; Takala-Harrison, S | 1 |
Crespo-Lladó, KN; Ferrer-Rodríguez, I; Ortiz, JG; Pastrana-Mena, R; Serrano, AE; Vega-Rodríguez, J | 1 |
Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
Alonso, D; Altman, S; Ben Mamoun, C; Deitsch, KW; Garg, A; Wesolowski, D | 1 |
DeFelipe, AP; Fontenla, F; Lamas, J; Leiro, JM; Mallo, N; Sueiro, RA | 1 |
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
Ajaiyeoba, EO; Fadare, AA; Fasinu, PS; Ogbole, OO; Saka, YA | 1 |
Bhardwaj, J; Goyal, M; Prakash, K; Puri, SK; Siddiqui, AJ; Soni, A | 1 |
Boudhar, A; Chia, WN; Dymock, BW; Loh, CY; Ng, XW; Nosten, F; Tan, KS; Tan, ZM | 1 |
Roberts, L | 1 |
Caillet, C; Guerin, PJ; Newton, PN | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Cassera, MB; Dalal, S; Ding, J; Kingston, DG; Liu, QF; Merino, EF; Wu, Y; Xu, CH; Yuan, T; Yue, JM; Zhou, B | 1 |
Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
Khositnithikul, R; Mungthin, M; Sitthichot, N; Suwandittakul, N; Ward, SA; Watanatanasup, E | 1 |
Bruneton, C; Guévart, E; Robin, S | 1 |
Deakin, J; Idris-Usman, M; Matthews, H; Nirmalan, NJ; Rajab, M | 1 |
Banura, P; Guler, JL; Houpt, E; Huang, F; Jacob, ST; Laufer, MK; Liu, J; Moore, CC; Pholwat, S; Stroup, S | 1 |
Amalvict, R; Bercion, R; Diatta, B; Diawara, S; Fall, B; Gueye, MW; Kounta, MB; Lo, G; Madamet, M; Nakoulima, A; Pradines, B; Wade, KA | 1 |
Adhin, MR; Barnwell, JW; Chenet, SM; Huber, CS; Kelley, J; Lucchi, N; Macedo de Oliveira, A; Okoth, SA; Udhayakumar, V; Vreden, S | 1 |
Chesnokova, O; Oleinikov, AV; Oleinikov, IV; Tcherniuk, SO | 1 |
Alokozai, A; Baktash, SH; Buhler, C; Cundill, B; Hasanzai, A; Laurent, B; Leslie, T; Mayan, I; Mikhail, A; Mohammed, N; Rahimi, HU; Rowland, M; Whitty, CJM; Willey, B; Wood, M | 1 |
Alam, MS; Auburn, S; Hossain, ME; Johora, FT; Khan, WA; Ley, B; Marfurt, J; Nima, MK; Price, RN; Thriemer, K | 1 |
Çavuş, İ; Kaya, T; Nuraydın, A; Özbilgin, A | 1 |
Aniweh, Y; Ansah, F; Awandare, GA; Chirawurah, JD; Duodu, S; Nyarko, PB | 1 |
Alexandre, MAA; Alves de Lima E Silva, JC; Daher, A; Dos Santos, TC; Lacerda, MVG; Lalloo, DG; Maia, I; Marchesini, P; Nascimento, CT; Pereira, D; Ruffato, R; Santelli, AC; Tada, M | 1 |
Bobade, D; Deshpande, P; Deval, M; Khandare, AV; Shastry, P | 1 |
Baska, KS; Dalal, S; Dhingra, SK; Fidock, DA; Garcia, CRS; Klein, MS; Klemba, M; Krishna, S; Lee, AH; Lewis, IA; Llinás, M; Roepe, PD; Rubiano, K; Singh, MK; Siriwardana, A | 1 |
Boncy, J; Existe, AV; Kano, S; Komaki-Yasuda, K; Vincent, JP | 1 |
Jiang, TL; Li, CH; Tang, T | 1 |
Asua, V; Conrad, MD; Dorsey, G; Kamya, MR; Kigozi, SP; Legac, J; Nsobya, SL; Rosenthal, PJ; Vinden, J | 1 |
Cumming, BM; Goldring, JPD | 1 |
Daher, A; Fontes, CJ; Lalloo, DG; Marchesini, P; Silva, JCAL; Stevens, A; Ter Kuile, FO | 1 |
Baird, JK; Cui, L; He, X; Huang, Y; Lu, Y; Pan, M; Pi, L; Qin, P; Qin, Y; Yang, Z; Zeng, W; Zhao, L; Zou, C | 1 |
Fotoran, WL; Irvine, DJ; Kleiber, N; Liebau, E; Miranda, BNM; Müntefering, T; Wunderlich, G | 1 |
Abuaku, B; Anto, F; Aydemir, O; Bailey, J; Ghansah, A; Hathaway, NJ; Marsh, PW; Mensah, BA; Myers-Hansen, JL; Opoku, M | 1 |
Barrett, MP; Hughes, KR; Rennie, MT; Roberts, AB; Simwela, NV; Waters, AP | 1 |
Batovska, DI; Markova, N; Medhi, B; Radotra, BD; Sehgal, R; Sinha, S | 1 |
Fidock, DA; Mok, S; Wicht, KJ | 1 |
Adeniyi, OM; Ajibaye, O; Aremu, OI; Asogwa, N; Babamale, OA; Fakayode, O; Fatoba, IM; Iyiola, OA; Omotesho, OB; Opeyemi, OA; Salawu, KM; Shittu, O | 1 |
Bhattacharyya, MK; Bhattacharyya, S; Bulusu, G; Jha, P; Padhi, S; Roy, A; Suthram, N | 1 |
Anywar, DA; Auma, MA; Balikagala, B; Emoto, S; Fukuda, N; Hashimoto, M; Hirai, M; Horii, T; Ikeda, M; Kataoka, M; Katuro, OT; Kimura, E; Mita, T; Mori, T; Obwoya, PS; Odongo-Aginya, EI; Ogwang, M; Opio, W; Palacpac, NMQ; Sakurai-Yatsushiro, M; Sekihara, M; Tachibana, SI; Yamauchi, M; Yatsushiro, S | 1 |
Coghi, P; Gianoncelli, A; Mastinu, A; Memo, M; Ng, JPL; Ribaudo, G; Wong, VKW; Yang, LJ | 1 |
Bamadio, A; Djimde, AA; Doumbo, OK; Grivoyannis, A; Maiga, H; Plowe, CV; Sagara, I; Sanogo, K; Tolo, Y; Traore, A; Traore, K; Traore, OB; Traore, ZI | 1 |
Andreu, D; Arce, EM; Avalos-Padilla, Y; Biosca, A; Bouzón-Arnáiz, I; Caño-Prades, O; Fernàndez-Busquets, X; Moita, D; Muñoz-Torrero, D; Prudêncio, M; Román-Álamo, L; Valle, J | 1 |
Chaijaroenkul, W; Jalei, AA; Muhamad, P; Na-Bangchang, K | 1 |
Baird, JK; Berni, A; Budiman, W; Cedar, E; Chand, K; Crenna-Darusallam, C; Duparc, S; Ekawati, LL; Elyazar, I; Fernando, D; Fletcher, K; Goyal, N; Green, JA; Instiaty, I; Jones, S; Kleim, JP; Lardo, S; Martin, A; Noviyanti, R; Prasetya, CB; Rolfe, K; Santy, YW; Satyagraha, AW; Sharma, H; Soebandrio, A; Subekti, D; Sutanto, I; Tan, LK; Taylor, M | 1 |
Abidah, HY; Endharti, AT; Fitri, LE; Huwae, JTR; Khotimah, ARH; Pawestri, AR; Winaris, N | 1 |
40 review(s) available for chloroquine and artemisinin
Article | Year |
---|---|
Tackling Fungal Resistance by Biofilm Inhibitors.
Topics: Animals; Antifungal Agents; Biofilms; Drug Discovery; Drug Resistance, Fungal; Fungi; Humans; Models, Molecular; Mycoses; Small Molecule Libraries | 2017 |
Quinoline hybrids and their antiplasmodial and antimalarial activities.
Topics: Antimalarials; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2017 |
Triazole derivatives and their antiplasmodial and antimalarial activities.
Topics: Animals; Antimalarials; Humans; Parasitic Sensitivity Tests; Plasmodium; Triazoles | 2019 |
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
Sattahipmycin, a Hexacyclic Xanthone Produced by a Marine-Derived
Topics: Escherichia coli; Gram-Positive Bacteria; Humans; Multigene Family; Streptomyces; Xanthones | 2022 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Advances in chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Malaria; Plasmodium; Plasmodium falciparum; Primaquine; Sesquiterpenes; Triazines | 1982 |
The treatment of malaria.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Prognosis; Sesquiterpenes | 1996 |
Is haemozoin a target for antimalarial drugs?
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Hemeproteins; Mice; Plasmodium; Sesquiterpenes | 1996 |
Combination therapy for malaria in Africa: hype or hope?
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Cross-Cultural Comparison; Half-Life; Humans; Insecticide Resistance; Malaria; Mefloquine; Pyrimethamine; Self Medication; Sesquiterpenes; Sulfadoxine; Thailand | 2000 |
Chemotherapeutic agents against malaria: what next after chloroquine?
Topics: Animals; Antimalarials; Artemisinins; Biological Factors; Chloroquine; Folic Acid Antagonists; Humans; Malaria; Protease Inhibitors; Quinine; Sesquiterpenes | 2002 |
Chloroquine and artemisinin: six decades of research--what next?
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Sesquiterpenes | 2003 |
WHO, the Global Fund, and medical malpractice in malaria treatment.
Topics: Africa; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Costs; Drug Resistance; Drug Therapy, Combination; Humans; International Agencies; Malaria; Malaria, Falciparum; Malpractice; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; World Health Organization | 2004 |
Management of severe malaria.
Topics: Adolescent; Age Distribution; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Combined Modality Therapy; Developing Countries; Endemic Diseases; Exchange Transfusion, Whole Blood; Female; Humans; Incidence; India; Infant; Malaria, Falciparum; Male; Quinine; Randomized Controlled Trials as Topic; Risk Assessment; Sesquiterpenes; Severity of Illness Index; Sex Distribution | 2004 |
Proteomic approaches to studying drug targets and resistance in Plasmodium.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Computational Biology; Computers; Drug Resistance; Gene Expression Profiling; Genes, Protozoan; Genome, Protozoan; Genomics; Humans; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mass Spectrometry; Plasmodium; Plasmodium falciparum; Plasmodium vivax; Proteomics; Protozoan Proteins; Sesquiterpenes; Software | 2004 |
Emerging drug--resistance and guidelines for treatment of malaria.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Pakistan; Phenanthrenes; Plasmodium falciparum; Quinidine; Quinine; Sesquiterpenes; Time Factors | 2004 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.
Topics: Africa; Amino Alcohols; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Biological Transport; Calcium-Transporting ATPases; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Gene Amplification; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Transporters involved in resistance to antimalarial drugs.
Topics: Animals; Antimalarials; Artemisinins; Calcium-Transporting ATPases; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes; Sodium-Hydrogen Exchangers | 2006 |
Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand.
Topics: Age Factors; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium; Quinine; Sesquiterpenes; Sex Factors; Sulfadoxine | 2007 |
Artemisinin and chloroquine: do mode of action and mechanism of resistance involve the same protagonists?
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drugs, Investigational; Humans; Malaria, Falciparum; Molecular Structure; Plasmodium falciparum; Sesquiterpenes | 2007 |
Lessons learnt from the six decades of chloroquine use (1945-2005) to control malaria in Madagascar.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Child; Chloroquine; Disease Outbreaks; Drug Resistance; Drug Therapy, Combination; Evidence-Based Practice; Health Policy; Humans; Madagascar; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins | 2009 |
Artemisinin combination therapy for vivax malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2010 |
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
The need for new antimalarial drugs less prone to resistance.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Design; Drug Resistance; Drug Therapy, Combination; Global Health; Humans; Malaria, Falciparum; Plasmodium falciparum | 2013 |
Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance.
Topics: Africa; Antimalarials; Artemisinins; Asia, Southeastern; Biological Evolution; Chloroquine; Drug Combinations; Drug Resistance; Gene Flow; Humans; Plasmodium falciparum; Pyrimethamine; South America; Sulfadoxine | 2012 |
Chemotherapy and drug resistance status of malaria parasite in northeast India.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Chloroquine; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Quinine | 2013 |
Role of traditional antimalarial plants in the battle against the global malaria burden.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Global Health; Humans; Malaria; Medicine, Traditional; Plant Components, Aerial; Plant Roots; Plants, Medicinal; Plasmodium; Quinine | 2013 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Antimalarial drug policy in India: past, present & future.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; India; Malaria; Plasmodium falciparum | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; History, 20th Century; History, 21st Century; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2015 |
Antimalarial drug resistance in Africa: key lessons for the future.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Forecasting; Humans; Malaria; Pyrimethamine; Sulfadoxine | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
[Research progress on heme metabolism in intraerythrocytic plasmodium].
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Erythrocytes; Heme; Hemoglobins; Humans; Plasmodium | 2018 |
Molecular Mechanisms of Drug Resistance in
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines | 2020 |
Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia.
Topics: Antimalarials; Artemisinins; Chloroquine; Humans; Indonesia | 2023 |
12 trial(s) available for chloroquine and artemisinin
Article | Year |
---|---|
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Models, Biological; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Recurrence; Sesquiterpenes | 2001 |
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Double-Blind Method; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Sesquiterpenes; Treatment Outcome; Vietnam | 2002 |
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Infections; Malaria; Male; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2006 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
Use of malaria rapid diagnostic tests by community health workers in Afghanistan: cluster randomised trial.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Community Health Workers; Diagnostic Tests, Routine; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Male; Plasmodium vivax; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial.
Topics: Adult; Aged; Artemisinins; Brazil; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Young Adult | 2018 |
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines | 2023 |
187 other study(ies) available for chloroquine and artemisinin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes | 2016 |
Selective anti-malarial minor groove binders.
Topics: Antimalarials; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2016 |
Antiprotozoal activity of bicycles featuring a dimethylamino group at their bridgehead.
Topics: Animals; Antiprotozoal Agents; Bridged Bicyclo Compounds; Cells, Cultured; Plasmodium falciparum; Rats; Spectrum Analysis; Structure-Activity Relationship; Trypanosoma brucei rhodesiense | 2016 |
Design, synthesis and evaluation of 4-aminoquinoline-purine hybrids as potential antiplasmodial agents.
Topics: Aminoquinolines; Animals; Antimalarials; Binding Sites; Drug Resistance, Fungal; Heme; Humans; Hypoxanthine Phosphoribosyltransferase; Molecular Docking Simulation; Plasmodium falciparum; Purines | 2017 |
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity.
Topics: Administration, Oral; Animals; Antimalarials; Disease Models, Animal; Mice; Plasmodium falciparum; Quinazolines; Structure-Activity Relationship | 2017 |
Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4-aminoquinoline-pyrimidine molecular hybrids.
Topics: Aminoquinolines; Animals; Antimalarials; Binding Sites; Cell Line; Heme; Humans; Molecular Docking Simulation; Multienzyme Complexes; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2017 |
New derivatives of quinoline-4-carboxylic acid with antiplasmodial activity.
Topics: Animals; Antimalarials; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Spectrum Analysis; Structure-Activity Relationship | 2017 |
Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Topics: Aniline Compounds; Antimalarials; Cysteine Endopeptidases; Hemeproteins; Humans; Malaria; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Quinolines; Structure-Activity Relationship | 2017 |
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
Topics: Amides; Animals; Antimalarials; Boron Compounds; Dogs; Female; Humans; Malaria; Malaria, Falciparum; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2017 |
4-Aminoquinoline-chalcone/-N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation.
Topics: Aminoquinolines; Antimalarials; Chalcone; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2017 |
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
Lead selection of antiparasitic compounds from a focused library of benzenesulfonyl derivatives of heterocycles.
Topics: Animals; Antiparasitic Agents; Benzyl Compounds; Dose-Response Relationship, Drug; Heterocyclic Compounds; Leishmania donovani; Molecular Structure; Myoblasts; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Structure-Activity Relationship; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2017 |
Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation.
Topics: Aminoquinolines; Antimalarials; Dose-Response Relationship, Drug; Microwaves; Molecular Structure; Parasitic Sensitivity Tests; Phthalimides; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
Sucupiranins A-L, Furanocassane Diterpenoids from the Seeds of Bowdichia virgilioides.
Topics: Antimalarials; Crystallography, X-Ray; Diterpenes; Fabaceae; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Nitric Oxide; Plasmodium falciparum; Seeds | 2017 |
A minimalistic approach to develop new anti-apicomplexa polyamines analogs.
Topics: Antiparasitic Agents; Apicomplexa; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polyamines; Structure-Activity Relationship; Toxoplasma | 2018 |
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen | 2018 |
Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
Topics: Animals; Anisoles; Antimalarials; Antineoplastic Agents; Antiviral Agents; Artemisinins; Benzofurans; Benzoquinones; Biological Products; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Cytomegalovirus; Humans; Molecular Conformation; Plasmodium falciparum | 2018 |
Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum.
Topics: Antimalarials; Apoptosis; Artemisinins; Benzaldehydes; Cell Line, Tumor; Cell Survival; Chalcones; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; HeLa Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
Topics: Animals; Antimalarials; Aspartic Acid Endopeptidases; Binding Sites; Cell Survival; Chlorocebus aethiops; Drug Design; Ethylamines; Hep G2 Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Plasmodium falciparum; Protein Structure, Tertiary; Structure-Activity Relationship; Vero Cells | 2018 |
MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
Topics: Aldose-Ketose Isomerases; Animals; Antimalarials; Female; Fosfomycin; Malaria, Falciparum; Mice; Plasmodium falciparum; Prodrugs; Structure-Activity Relationship | 2018 |
N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies.
Topics: Aminoquinolines; Animals; Antimalarials; Chlorocebus aethiops; Heme; Molecular Docking Simulation; Plasmodium falciparum; Pyrimidines; Vero Cells | 2019 |
Antiprotozoal Isoprenoids from Salvia hydrangea.
Topics: Animals; Antiprotozoal Agents; Cell Line; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Plasmodium falciparum; Rats; Salvia; Spectrum Analysis; Terpenes; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2018 |
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents.
Topics: Animals; Antiprotozoal Agents; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Drug Evaluation, Preclinical; Humans; Imidazoles; Parasitic Sensitivity Tests; Trypanosoma | 2019 |
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing
Topics: | 2019 |
4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Disease Models, Animal; Drug Evaluation, Preclinical; Malaria; Mice; Microsomes, Liver; Pyrrolidines; Structure-Activity Relationship | 2019 |
Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
Topics: Animals; Antimalarials; Cell Line; Cell Survival; Disease Models, Animal; Drug Resistance; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2019 |
Falcipain Inhibitors Based on the Natural Product Gallinamide A Are Potent in Vitro and in Vivo Antimalarials.
Topics: Animals; Antimalarials; Antimicrobial Cationic Peptides; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Female; Inhibitory Concentration 50; Mice; Plasmodium falciparum | 2019 |
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
Topics: Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Malaria, Falciparum; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrvinium Compounds; Structure-Activity Relationship; Tuberculosis | 2020 |
Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermis; Escherichia coli; Female; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Rats; Salts; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
In vitro and in vivo antiplasmodial activity of novel quinoline derivative compounds by molecular hybridization.
Topics: Animals; Antimalarials; Cell Line; Erythrocytes; Female; Hemeproteins; Hemin; Hemolysis; Humans; Malaria; Mice; Plasmodium falciparum; Quinolines | 2021 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials.
Topics: Administration, Oral; Animals; Antimalarials; Humans; Malaria, Falciparum; Mice; Molecular Structure; Plasmodium falciparum; Quinazolinones; Structure-Activity Relationship | 2021 |
Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials
Topics: | 2022 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Butylated Hydroxytoluene; Chloroquine; Drug Resistance; Drugs, Chinese Herbal; Mefloquine; Molecular Structure; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Sesquiterpenes; Thailand | 1991 |
Premature release of Plasmodium falciparum from swollen erythrocytes induced by some antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Azure Stains; Cells, Cultured; Chloroquine; Erythrocyte Membrane; Erythrocytes; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes | 1989 |
The potentiating action of tetrandrine in combination with chloroquine or qinghaosu against chloroquine-sensitive and resistant falciparum malaria.
Topics: Alkaloids; Animals; Antimalarials; Artemisinins; Benzylisoquinolines; Chloroquine; Drug Resistance; Drug Synergism; Malaria; Plasmodium falciparum; Sesquiterpenes; Species Specificity | 1989 |
Plasmodium falciparum: inhibition of dolichol kinase by mefloquine.
Topics: Animals; Artemisinins; Cations, Divalent; Chloroquine; Cytidine Triphosphate; Detergents; Dolichols; Egtazic Acid; Erythrocytes; Hydrogen-Ion Concentration; Kinetics; Mefloquine; Microsomes; Nucleotides; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Plasmodium falciparum; Quinolines; Sesquiterpenes; Trifluoperazine | 1986 |
X-ray microanalysis of Plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Electrolytes; Electron Probe Microanalysis; Erythrocytes; Humans; In Vitro Techniques; Phosphorus; Plasmodium falciparum; Potassium; Sesquiterpenes; Sodium | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Fluorometric determination of the antimalarial efficacy of artemisinin and artemether against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Plasmodium falciparum; Sesquiterpenes; Spectrometry, Fluorescence | 1988 |
1,2,4-Trioxanes as potential antimalarial agents.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1988 |
[Development of a qinghaosu-resistant line of Plasmodium berghei ANKA and N strain].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Microbial; Malaria; Male; Mice; Plasmodium berghei; Primaquine; Pyrans; Sesquiterpenes | 1986 |
Effect of artemisinin (qinghaosu) and chloroquine on drug-sensitive and drug-resistant strains of Plasmodium falciparum malaria: use of [2,8-3H]adenosine as an alternative to [G-3H]hypoxanthine in the assessment of in vitro antimalarial activity.
Topics: Adenosine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Erythrocytes; Humans; Hypoxanthine; Hypoxanthines; Malaria; Mice; Plasmodium falciparum; Sesquiterpenes | 1987 |
In vitro chloroquine resistant Plasmodium falciparum in Calcutta and its sensitivity to qinghaosu (artemisitene).
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drugs, Chinese Herbal; Humans; India; Plasmodium falciparum; Sesquiterpenes | 1987 |
Qinghaosu resistance in rodent malaria.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Malaria; Male; Mice; Plasmodium; Plasmodium berghei; Sesquiterpenes | 1986 |
The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Plasmodium falciparum; Sesquiterpenes | 1987 |
Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether.
Topics: Animals; Artemether; Artemisinins; Chloroquine; Drug Combinations; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thailand | 1985 |
[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1985 |
Effects of Qinghaosu and chloroquine on the ultrastructure of the erythrocytic stage of P. falciparum in continuous cultivation in vitro.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Erythrocytes; Microscopy, Electron; Plasmodium falciparum; Sesquiterpenes | 1983 |
The treatment of falciparum malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Quinidine; Quinine; Quinolines; Sesquiterpenes | 1984 |
[Antimalarial activities of 25 derivatives of artemisinine against chloroquine-resistant plasmodium berghei (author's transl)].
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Male; Mice; Plasmodium berghei; Pyrans; Sesquiterpenes; Structure-Activity Relationship | 1980 |
[Observation of therapeutic effect of single-dose combined administration of Qinghaosu, sulphomethoxine, pyrimethamine and primaquine in the treatment of chloroquine-resistant malignant malaria (author's transl)].
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Middle Aged; Primaquine; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfamethazine | 1981 |
A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Blotting, Southern; Chloroquine; DNA Primers; DNA, Protozoan; Drug Resistance; Gene Amplification; Gene Expression; Genes, Protozoan; Mefloquine; Molecular Sequence Data; Phenanthrenes; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; RNA, Messenger; Selection, Genetic; Sequence Homology, Nucleic Acid; Sesquiterpenes | 1994 |
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Mefloquine; Naphthyridines; Phenanthrenes; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Triazines | 1994 |
Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes.
Topics: alpha-Thalassemia; Animals; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Drug Resistance; Erythrocytes; Hemoglobin H; Hemoglobins, Abnormal; Humans; Plasmodium falciparum; Reference Values; Sesquiterpenes | 1994 |
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 1993 |
Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.
Topics: Animals; Antimalarials; Artemisinins; Cell Differentiation; Chloroquine; Drugs, Chinese Herbal; Hypoxanthine; Hypoxanthines; Lactates; Plasmodium falciparum; Protozoan Proteins; Quinine; Sesquiterpenes | 1993 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Chloroquine; Drugs, Chinese Herbal; Plasmodium falciparum; Sesquiterpenes | 1996 |
In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes; Vietnam | 1997 |
Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Erythromycin; Plasmodium falciparum; Protein Synthesis Inhibitors; Sesquiterpenes; Tetracycline | 1994 |
In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Humans; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania | 1997 |
Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Design; Drug Evaluation, Preclinical; Heterocyclic Compounds; Plasmodium falciparum; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 1998 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Evaluation, Preclinical; Drug Resistance; France; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes; Travel | 1998 |
Antimalarial drug resistance and combination chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes | 1999 |
Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogues that block the network.
Topics: Animals; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Drug Resistance; Drug Synergism; Erythrocytes; Fluorescent Antibody Technique, Indirect; Humans; Malaria, Falciparum; Membrane Proteins; Microscopy, Electron; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes; Sphingolipids; Vacuoles | 1999 |
Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Erythrocytes; Humans; Metalloporphyrins; Plasmodium falciparum; Sesquiterpenes | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Animals; Antimalarials; Artemisinins; Cell-Free System; Chloroquine; Cytochrome-B(5) Reductase; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Erythrocytes; Macaca mulatta; Methemoglobin; Methemoglobinemia; Muridae; Oxyhemoglobins; Primaquine; Rats; Sesquiterpenes | 2000 |
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
Topics: Amino Acid Substitution; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Mefloquine; Mutation; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Sesquiterpenes; Verapamil | 2000 |
In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Chloroquine; Drug Resistance; Drug Synergism; Humans; Malaria, Falciparum; Metalloporphyrins; Mice; Peroxides; Plasmodium falciparum; Sesquiterpenes | 2000 |
Potent in vivo antimalarial activity of 3,15-di-O-acetylbruceolide against Plasmodium berghei infection in mice.
Topics: Animals; Antimalarials; Artemisinins; Carbolines; Chloroquine; Dose-Response Relationship, Drug; Malaria; Male; Mice; Mice, Inbred ICR; Plasmodium berghei; Pyridones; Random Allocation; Sesquiterpenes | 2000 |
Malaria epidemic in Burundi.
Topics: Antimalarials; Artemisinins; Burundi; Chloroquine; Disease Outbreaks; Drug Therapy, Combination; Humans; Malaria, Falciparum; Sesquiterpenes | 2001 |
Synthesis of new artemisinin analogues from artemisinic acid modified at C-3 and C-13 and their antimalarial activity.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Chromatography, Thin Layer; Drug Resistance, Microbial; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; KB Cells; Magnetic Resonance Spectroscopy; Molecular Structure; Plasmodium falciparum; Sesquiterpenes; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Structure-Activity Relationship | 2001 |
In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2001 |
Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Heme; Plasmodium yoelii; Polymers; Protein Binding; Proteins; Sesquiterpenes | 2002 |
Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2002 |
Effect of antimalarial drugs on plasmodia cell-free protein synthesis.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Electrophoresis, Polyacrylamide Gel; Plasmodium falciparum; Primaquine; Protein Biosynthesis; Protein Synthesis Inhibitors; Protozoan Proteins; RNA, Messenger; Sesquiterpenes | 2002 |
Parasitology. A requiem for chloroquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Drug Tolerance; Evolution, Molecular; Genes, Protozoan; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes; Tetrahydrofolate Dehydrogenase | 2002 |
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Genes, Protozoan; Haplotypes; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes; Transfection; Verapamil | 2002 |
Therapeutic efficacies of antimalarial drugs in the treatment of uncomplicated, Plasmodium falciparum malaria in Assam, north-eastern India.
Topics: Adolescent; Adult; Aged; Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; DNA Damage; DNA Repair; Drug Resistance; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfanilamide; Sulfanilamides; Ultraviolet Rays | 2004 |
Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.
Topics: Ammonium Chloride; Animals; Antimalarials; Artemisinins; Biotin; Blotting, Western; Chloroquine; Dextrans; Endocytosis; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Hemoglobins; Mefloquine; Microscopy, Electron; Microscopy, Fluorescence; Monensin; Plasmodium falciparum; Quinolones; Sesquiterpenes; Transport Vesicles; Vacuoles | 2004 |
Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Carbon Monoxide; Chloroquine; Erythrocytes; Heme; Hemoglobins; Humans; Iron; Malaria; Oxidation-Reduction; Oxidative Stress; Oxygen; Plasmodium falciparum; Sesquiterpenes | 2004 |
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.
Topics: Alleles; Animals; Anopheles; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance; Drug Therapy, Combination; Genotype; Humans; Malaria; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes | 2004 |
ATPase activity of purified plasma membranes and digestive vacuoles from Plasmodium falciparum.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemisinins; Cell Membrane; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Subcellular Fractions; Vacuoles | 2005 |
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community.
Topics: Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Malaria, Falciparum; Male; Patient Acceptance of Health Care; Population Surveillance; Pyrimethamine; Rural Health; Self Administration; Sesquiterpenes; Sulfadoxine; Tanzania | 2005 |
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins.
Topics: Animals; Artemisinins; Chloroquine; Drug Resistance; Drug Synergism; Erythrocytes; Methylene Blue; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2005 |
[Malaria: a medical and economic problem].
Topics: Anti-Infective Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes; Survival Rate; World Health Organization | 2006 |
[The microfluorimetric assay (MFA) in in vitro testing the sensitivity of Plasmodium falciparum to antimalarial drugs].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Cytophotometry; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Reproducibility of Results | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
In vitro interaction between artemisinin and chloroquine as well as desbutyl-benflumetol in Plasmodium vivax.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Ethanolamines; Fluorenes; Humans; In Vitro Techniques; Parasitic Sensitivity Tests; Plasmodium vivax; Sesquiterpenes; Thailand | 2006 |
Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme.
Topics: Animals; Artemisinins; Brain Neoplasms; Chloroquine; Cyclic N-Oxides; Glioblastoma; Hemin; Humans; Intracellular Membranes; Iron; Lipid Peroxidation; Lysosomes; Membrane Lipids; Oxidants; Oxidation-Reduction; Oxidative Stress; Plasmodium; Radiation-Sensitizing Agents; Sesquiterpenes; Spin Labels | 2006 |
Antimalarial drugs disrupt ion homeostasis in malarial parasites.
Topics: Acridine Orange; Animals; Antimalarials; Artemisinins; Chloroquine; Erythrocytes; Female; Fluorescent Dyes; Homeostasis; Hydrogen-Ion Concentration; Ion Channels; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Plasmodium chabaudi | 2007 |
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites.
Topics: Amino Acid Sequence; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Female; Genes, Protozoan; Humans; Mice; Mice, Inbred CBA; Models, Molecular; Mutation; Parasitic Sensitivity Tests; Plasmodium chabaudi; Sesquiterpenes; Ubiquitin | 2007 |
Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs).
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy; Drug Therapy, Combination; Humans; Malaria; Malawi; Pyrimethamine; Rwanda; Senegal; Sulfadoxine; Tanzania; Zimbabwe | 2007 |
Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine.
Topics: Alkylation; Animals; Antimalarials; Artemisinins; Chloroquine; Dioxanes; Heme; Hemeproteins; Plasmodium; Sesquiterpenes; Spectrophotometry, Infrared | 2007 |
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.
Topics: Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lethal Dose 50; Malaria, Vivax; Mefloquine; Plasmodium vivax; Survival Rate; Thailand; Treatment Outcome | 2007 |
From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Planning Guidelines; Health Policy; Humans; Lumefantrine; Malaria; Zambia | 2008 |
Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Genetic Markers; Malaria, Falciparum; Mali; Parasitic Sensitivity Tests; Plasmodium falciparum | 2008 |
Malaria control in South Africa - challenges and successes.
Topics: Anti-Infective Agents; Antimalarials; Artemisinins; Chloroquine; History, 19th Century; History, 20th Century; HIV Infections; Humans; Malaria; Mosquito Control; South Africa; Travel | 2007 |
In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance, Microbial; Global Health; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum | 2008 |
In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum.
Topics: Amphotericin B; Animals; Antimalarials; Artemisinins; Chloroquine; Clotrimazole; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Hot Temperature; Plasmodium falciparum | 2008 |
[Self-medication in the treatment of acute malaria: study based on users of private health drug stores in Ouagadougou, Burkina Faso].
Topics: Acute Disease; Adult; Antimalarials; Artemisinins; Burkina Faso; Child; Chloroquine; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Utilization; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Male; Middle Aged; Motivation; Pharmacies; Pyrimethamine; Self Medication; Sulfadoxine; Urban Population | 2008 |
The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum.
Topics: Adenosine Triphosphate; Animals; Antimalarials; Artemisinins; Chloroquine; Deoxyglucose; Fluorodeoxyglucose F18; Glycolysis; Hydrogen-Ion Concentration; Phosphorylation; Plasmodium falciparum | 2008 |
Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Developing Countries; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Evidence-Based Medicine; Female; Fluorenes; Health Surveys; Humans; Incidence; Infant; Lumefantrine; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Refugees; Uganda; Young Adult | 2008 |
Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
Topics: Animals; Antimalarials; Artemisinins; Benzothiazoles; Chloroquine; Diamines; Drug Combinations; Drug Evaluation, Preclinical; Drug Interactions; Fluorescent Dyes; Hypoxanthine; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2009 |
Dual labeling with a far red probe permits analysis of growth and oxidative stress in P. falciparum-infected erythrocytes.
Topics: Animals; Artemisinins; Catalase; Chloroquine; Cysteine Proteases; Erythrocytes; Flow Cytometry; Fluorescent Dyes; Humans; Malaria; Models, Biological; Nucleic Acids; Oxidative Stress; Oxygen; Plasmodium falciparum | 2010 |
A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in Senegal.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Fluorescent Dyes; Genotype; Humans; Indoles; Malaria, Falciparum; Plasmodium falciparum; Senegal; Staining and Labeling | 2010 |
Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes.
Topics: Anti-Infective Agents; Antimalarials; Artemisinins; Chloroquine; Drug Evaluation, Preclinical; Flow Cytometry; Inhibitory Concentration 50; Malaria, Falciparum; Microscopy; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Primaquine; Xanthurenates | 2010 |
Demand for malaria drug soars.
Topics: Agriculture; Artemisia annua; Artemisinins; Chloroquine; Drug Costs; Drug Resistance; Humans; Malaria | 2010 |
Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Synergism; Erythrocytes; Flow Cytometry; Humans; Phytosterols; Plasmodium falciparum; Quinine; Solanum; Trophozoites | 2011 |
Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.
Topics: Antimalarials; Antiviral Agents; Artemisinins; Cells, Cultured; Chloroquine; Enzyme-Linked Immunosorbent Assay; HIV Core Protein p24; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocytes; Pyrimethamine; Virus Replication | 2010 |
Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Ethanolamines; Fluorenes; Lumefantrine; Malaria; Male; Mice; Naphthoquinones; Plasmodium berghei; Pyrimethamine; Random Allocation | 2011 |
Epidemic of Plasmodium falciparum malaria in Central India, an area where chloroquine has been replaced by artemisinin-based combination therapy.
Topics: Adolescent; Age Distribution; Antimalarials; Artemisinins; Child; Chloroquine; Drug Therapy, Combination; Epidemics; Female; Humans; India; Infant; Infant, Newborn; Insecticide Resistance; Insecticides; Malaria, Falciparum; Male; Prevalence; Rural Health; Treatment Outcome | 2011 |
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malaria, Vivax; Nepal; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2011 |
Synthesis and in vitro antimalarial activity of tetraoxane-amine/amide conjugates.
Topics: Amides; Amines; Animals; Antimalarials; Artemisinins; Cell Line, Tumor; Chlorocebus aethiops; Chloroquine; Dose-Response Relationship, Drug; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes; Vero Cells | 2011 |
Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Lethal Dose 50; Mefloquine; Plasmodium vivax; Thailand | 2011 |
Extracellular heme enhances the antimalarial activity of artemisinin.
Topics: Antimalarials; Antioxidants; Artemisia; Artemisinins; Chloroquine; Cholesterol, LDL; Fluorescence; Heme; Hemin; Humans; Lipid Peroxidation; Mefloquine; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Quinine; Tryptophan; Vitamin E | 2012 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Synergism; Harmaline; Harmine; HSP90 Heat-Shock Proteins; Malaria; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Plasmodium berghei; Plasmodium falciparum; Protein Structure, Quaternary; Protein Structure, Tertiary; Surface Plasmon Resonance | 2012 |
In vitro susceptibility of Plasmodium falciparum Welch field isolates to infusions prepared from Artemisia annua L. cultivated in the Brazilian Amazon.
Topics: Antimalarials; Artemisia annua; Artemisinins; Brazil; Chloroquine; Drug Synergism; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Plant Extracts; Plasmodium falciparum; Quinine | 2012 |
Too much to ask.
Topics: Africa; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria | 2012 |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Erythrocytes; Flow Cytometry; High-Throughput Screening Assays; Hydroxamic Acids; Inhibitory Concentration 50; Mefloquine; Merozoites; Plasmodium falciparum; Quinine; Quinolines; Schizonts; Time Factors | 2013 |
Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
Topics: Antimalarials; Artemisinins; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Chloroquine; Chromatography, Gel; Cysteine Endopeptidases; Hemeproteins; Hemoglobins; Immunoprecipitation; Mass Spectrometry; Multiprotein Complexes; Plasmodium falciparum; Polymerization; Proteolysis; Protozoan Proteins | 2013 |
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |
Comparative study of antimalarial effect of sambiloto (Andrographis paniculata) extract, chloroquine and artemisinin and their combination against plasmodium falciparum in-vitro.
Topics: Andrographis; Antimalarials; Artemisinins; Cells, Cultured; Chloroquine; Drug Therapy, Combination; Erythrocytes; Humans; Parasitic Sensitivity Tests; Plant Extracts; Plant Stems; Plasmodium falciparum | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
An image analysis algorithm for malaria parasite stage classification and viability quantification.
Topics: Algorithms; Antimalarials; Artemisinins; Cell Survival; Cells, Cultured; Chloroquine; Erythrocytes; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Indoles; Inhibitory Concentration 50; Microscopy, Fluorescence; Mitochondria; Organic Chemicals; Plasmodium falciparum; Spores, Protozoan | 2013 |
Pro-oxidant properties of indolone-N-oxides in relation to their antimalarial properties.
Topics: Antimalarials; Artemisinins; Chloroquine; Cyclic N-Oxides; Cysteine; Electron Spin Resonance Spectroscopy; Enzyme Activation; Erythrocyte Membrane; Heme; Hemin; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Iron; Models, Biological; Models, Chemical; Oxidation-Reduction; Protein-Tyrosine Kinases; Reactive Oxygen Species; Solutions; Syk Kinase | 2013 |
Antimalarial and cytotoxic activities of chiral triamines.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Cell Survival; Chloroquine; Cyclization; Humans; Plasmodium falciparum; Polyamines; Small Molecule Libraries | 2013 |
An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites.
Topics: Antimalarials; Artemisinins; Binding Sites; Chloroquine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Resistance; Erythrocytes; Ferrous Compounds; Hemoglobins; Humans; Malaria; Molecular Docking Simulation; Plasmodium falciparum; Protein Structure, Tertiary; Structure-Activity Relationship; Sulfones; Tetraoxanes | 2013 |
Trends in antimalarial drug use in Africa.
Topics: Africa; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Health Surveys; Humans; Malaria, Falciparum; Models, Statistical; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 2013 |
Model system to define pharmacokinetic requirements for antimalarial drug efficacy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Humans; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Models, Biological; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Reproducibility of Results; Treatment Outcome | 2013 |
Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
Topics: Antimalarials; Apoptosis; Artemisinins; Benzaldehydes; Cell Survival; Cells, Cultured; Chalcones; Chloroquine; Dose-Response Relationship, Drug; Drug Design; Drug Resistance; Fibroblasts; HeLa Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2014 |
Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.
Topics: Amodiaquine; Amoxicillin; Antimalarials; Artemether; Artemisinins; Biosimilar Pharmaceuticals; Chloroquine; Drug Resistance; Health Facilities; Humans; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Primaquine; Quality Control; Quinine | 2014 |
Design, synthesis and evaluation of new tricyclic endoperoxides as potential antiplasmodial agents.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Chloroquine; Drug Design; Erythrocytes; Free Radicals; Humans; Hypoxanthine; Inhibitory Concentration 50; Iron; Oxidation-Reduction; Peroxides; Plasmodium falciparum; Tritium | 2014 |
Chloroquine remains effective for treating Plasmodium vivax malaria in Pursat province, Western Cambodia.
Topics: Anti-Infective Agents; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Malaria; Plasmodium vivax | 2014 |
Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Codon; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; India; Malaria, Falciparum; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2014 |
Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells.
Topics: Artemisia; Artemisinins; Breast Neoplasms; Cell Survival; Chlorogenic Acid; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Plant Extracts | 2014 |
Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Topics: Amino Acid Sequence; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Chromosomes; Drug Resistance, Multiple; Erythrocytes; Humans; INDEL Mutation; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines; Thailand | 2014 |
Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Synergism; Humans; Membrane Potential, Mitochondrial; Reactive Oxygen Species | 2014 |
Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin.
Topics: Animals; Artemisinins; Chloroquine; Drug Resistance; Glutamate-Cysteine Ligase; Glutathione; Malaria; Mice; Plasmodium berghei; Protozoan Proteins | 2015 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Down-Regulation; Drug Resistance; Flow Cytometry; Genes, Reporter; Hemiterpenes; Luciferases; Morpholinos; Organophosphorus Compounds; Parasites; Peptides; Plasmodium falciparum; Protein Biosynthesis; Proteolysis; RNA Splicing; RNA, Messenger; Sequence Analysis, DNA | 2015 |
Enzymes Involved in Pyrophosphate and Calcium Metabolism as Targets for Anti-scuticociliate Chemotherapy.
Topics: Animals; Artemisinins; Calcium; Chloroquine; Ciliophora; Ciliophora Infections; Diphosphates; Fish Diseases; Flatfishes; Homeostasis; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Inorganic Pyrophosphatase | 2016 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Antimalarial and cytotoxic properties of Chukrasia tabularis A. Juss and Turraea vogelii Hook F. Ex. Benth.
Topics: Animals; Antimalarials; Artemia; Artemisinins; Cell Survival; Chloroquine; Drug Resistance; Malaria; Male; Meliaceae; Mice; Plant Bark; Plant Extracts; Plant Stems; Plasmodium berghei; Plasmodium falciparum | 2016 |
Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Topics: Animals; Antimalarials; Artemisinins; Chemoprevention; Chloroquine; Female; Immunization; Malaria; Mefloquine; Mice; Parasite Load; Plasmodium yoelii; Primaquine; Sporozoites; Vaccination | 2016 |
Overcoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds.
Topics: Antimalarials; Artemisinins; Chloroquine; Plasmodium falciparum; Structure-Activity Relationship | 2016 |
Malaria wars.
Topics: Antimalarials; Artemisinins; Cambodia; Chloroquine; Disease Eradication; Drug Resistance, Microbial; Humans; Malaria, Falciparum; Mekong Valley; Plasmodium falciparum | 2016 |
A link between poor quality antimalarials and malaria drug resistance?
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Nanomolar Antimalarial Agents against Chloroquine-Resistant Plasmodium falciparum from Medicinal Plants and Their Structure-Activity Relationships.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Inhibitory Concentration 50; Magnoliopsida; Molecular Structure; Plants, Medicinal; Plasmodium falciparum; Structure-Activity Relationship | 2017 |
Influence of the
Topics: Alleles; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gene Dosage; Genotyping Techniques; Inhibitory Concentration 50; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Thailand | 2017 |
[Practices of caregivers and national recommendations for treatment of malaria in Benin in 2009].
Topics: Antimalarials; Artemisinins; Attitude of Health Personnel; Benin; Caregivers; Chloroquine; Cross-Sectional Studies; Drug Therapy, Combination; Female; Guideline Adherence; Health Knowledge, Attitudes, Practice; Humans; Malaria; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires | 2017 |
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Computational Biology; Drug Combinations; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Emetine; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil | 2017 |
The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Epidemiological Monitoring; Genotyping Techniques; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Reagent Kits, Diagnostic; Sulfadoxine | 2017 |
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Plasmodium falciparum; Senegal | 2017 |
Molecular Profile of Malaria Drug Resistance Markers of Plasmodium falciparum in Suriname.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Genotype; Malaria; Mutation; Plasmodium falciparum; Protozoan Proteins; Suriname | 2017 |
Nicotinamide inhibits the growth of P. falciparum and enhances the antimalarial effect of artemisinin, chloroquine and pyrimethamine.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Erythrocytes; Humans; Life Cycle Stages; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine | 2017 |
Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.
Topics: Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Bangladesh; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Sequence Analysis, DNA | 2017 |
In vivo and in vitro Models for Scanning Drug Substances in Malaria: Prestudy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Evaluation, Preclinical; In Vitro Techniques; Malaria; Male; Mice; Mice, Inbred BALB C; Plant Extracts; Plasmodium berghei; Tetracycline | 2017 |
Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Ghana; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum | 2017 |
Hemozoin-induced activation of human monocytes toward M2-like phenotype is partially reversed by antimalarial drugs-chloroquine and artemisinin.
Topics: Antimalarials; Artemisinins; Cell Differentiation; Chloroquine; Hemeproteins; Humans; Immunologic Factors; Monocytes | 2019 |
Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.
Topics: Amodiaquine; Antimalarials; Artemisinins; Calcium; Cells, Cultured; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Gene Expression; Hemoglobins; Host-Parasite Interactions; Humans; Ion Transport; Ionophores; Membrane Transport Proteins; Monensin; Mutation; Nigericin; Plasmodium falciparum; Protozoan Proteins; Pyrrolidinones | 2018 |
No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Haiti; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Surveys and Questionnaires; Young Adult | 2018 |
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Aspartic Acid Endopeptidases; Child; Chloroquine; Drug Resistance; Folic Acid Antagonists; Humans; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Uganda | 2019 |
Monocyte phagocytosis of malaria β-haematin in the presence of artemisinin, amodiaquine, chloroquine, doxycycline, primaquine, pyrimethamine and quinine.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Cell Count; Cell Line; Chloroquine; Doxycycline; Electron Probe Microanalysis; Heme; Hemeproteins; Humans; Leukocytes, Mononuclear; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Monocytes; Peroxidase; Phagocytosis; Primaquine; Pyrimethamine; Quinine; Spectrophotometry; Temperature; U937 Cells | 2019 |
Evaluation of Plasmodium vivax malaria recurrence in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Brazil; Child; Child, Preschool; Chloroquine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Vivax; Male; Middle Aged; Primaquine; Recurrence; Retrospective Studies; Time Factors; Young Adult | 2019 |
Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Cytochrome P-450 CYP2D6; Ghana; Humans; Inactivation, Metabolic; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Recurrence | 2019 |
A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Cross-Linking Reagents; Drug Delivery Systems; Hydrogen Bonding; Liposomes; Malaria, Falciparum; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Particle Size; Plasmodium falciparum; Treatment Outcome | 2019 |
Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ghana; High-Throughput Nucleotide Sequencing; Humans; Infant; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2020 |
Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate
Topics: Africa; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Hydrolases; Malaria, Falciparum; Mutation; Plasmodium berghei; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Ubiquitin | 2020 |
Ultrastructural alterations in Plasmodium falciparum induced by chalcone derivatives.
Topics: Antimalarials; Artemisinins; Cells, Cultured; Chalcones; Chloroquine; Erythrocytes; Microscopy, Electron, Transmission; Plasmodium falciparum | 2020 |
Clinical Probe of Cyp2C8*2 Mutants in a Malaria Hyperendemic Zone: Evidence from North-Central, Nigeria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Cytochrome P-450 CYP2C8; Drug Resistance; Female; Humans; Malaria; Male; Nigeria; Pharmacogenomic Testing; Plasmodium falciparum | 2020 |
Elucidation of DNA Repair Function of PfBlm and Potentiation of Artemisinin Action by a Small-Molecule Inhibitor of RecQ Helicase.
Topics: Antimalarials; Artemisinins; Chloroquine; DNA Repair; Enzyme Inhibitors; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; RecQ Helicases | 2020 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Lumefantrine; Mefloquine; Plasmodium falciparum; Quinine; Uganda | 2021 |
Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD).
Topics: Angiotensin-Converting Enzyme 2; Antimalarials; Antiviral Agents; Artemisinins; Binding Sites; Chloroquine; COVID-19 Drug Treatment; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Selection of
Topics: Alleles; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins | 2021 |
The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures.
Topics: Amyloid beta-Peptides; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Protein Aggregates; Proteome | 2022 |
Monitoring antimalarial drug-resistance markers in Somalia.
Topics: Antimalarials; Chloroquine; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Somalia | 2023 |